Screening and quantitative analysis for sulfonylurea-type oral antidiabetic agents in adulterated health food using thin-layer chromatography and high-performance liquid chromatography

被引:28
作者
Kumasaka, K
Kojima, T
Honda, H
Doi, K
机构
[1] Kanagawa Prefectural Inst Publ Hlth, Div Chem, Chigasaki, Kanagawa 2530087, Japan
[2] Showa Univ, Sch Med, Dept Physiol 2, Shinagawa Ku, Tokyo 1428555, Japan
[3] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Pharmacol, Hachioji, Tokyo 1920392, Japan
关键词
sulfonylurea-type oral antidiabetic agent; screening; health food; thin-layer chromatography; high-performance liquid chromatography;
D O I
10.1248/jhs.51.453
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Screening and quantitative analysis for six sulfonylurea-type oral antidiabetic agents (SU-OADs), tolbutamide (TOL), acetohexamide (ACE), chlorpropamide (CHL), gliclazide (GLC), glibenclamide (GLB), and glimepiride (GLM), in adulterated health food has been developed. The SU-OADs were extracted with acetone and then the extract was subjected to thin-layer chromatography (TLC) and high-performance liquid chromatography (HPLC). In the TLC analysis, good separation was achieved with a mixture of n-butyl acetate containing 0.4% formic acid as a solvent. Ultraviolet irradiation at 254 nm was used to detect the SU-OADs. Specificity was obtained with Dragendorff's test solution, 10% phosphomolybdic acid methanol solution, and 30% sulfuric acid methanol solution. On the other hand, with a gradient reverse-phase HPLC system equipped with a photodiode array detector, we were able to detect the SU-OADs within 15 min using an ODS column and acetonitrile-ammonium acetate buffer as a mobile phase. Quantitative analysis based on HPLC was also performed with the absolute calibration curve method. Recoveries were 90.7-105.2% for the drugs tested. The intra- and interassay relative standard deviations were 0.2-8.1 and 0.6-7.2%, respectively. When the methods were applied to prescription glibenclamide tablets, health food, and spiked samples, good selectivity, separation, recovery, and precision were obtained.
引用
收藏
页码:453 / 460
页数:8
相关论文
共 10 条
[1]  
DOI K, 1999, B KANAGAWA P H LAB, V30, P92
[2]   Origin of sennosides in dietary supplements containing senna stem [J].
Kojima, T ;
Kishi, M ;
Sekita, S ;
Satake, M .
JOURNAL OF THE FOOD HYGIENIC SOCIETY OF JAPAN, 2000, 41 (05) :303-306
[3]   Analysis of synthetic anti-diabetic drugs in adulterated traditional Chinese medicines by high-performance capillary electrophoresis [J].
Ku, YR ;
Chag, LY ;
Ho, LK ;
Lin, JH .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 33 (02) :329-334
[4]   Analysis of the oral hypoglycemic agent, glibenclamide, in a health food [J].
Kumasaka, K ;
Kojima, T ;
Doi, K ;
Satoh, S .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2003, 123 (12) :1049-1054
[5]   Identification of sulfonylureas in serum by electrospray mass spectrometry [J].
Magni, F ;
Marazzini, L ;
Pereira, S ;
Monti, L ;
Kienle, MG .
ANALYTICAL BIOCHEMISTRY, 2000, 282 (01) :136-141
[6]   Screening, library-assisted identification and validated quantification of oral antidiabetics of the sulfonylurea-type in plasma by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry [J].
Maurer, HH ;
Kratzsch, C ;
Kraemer, T ;
Peters, FT ;
Weber, AA .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 773 (01) :63-73
[7]  
*MIN HLTH LAB WELF, 2001, JAP PHARM
[8]   Identification system for sildenafil in health foods [J].
Moriyasu, T ;
Shigeoka, S ;
Kishimoto, K ;
Ishikawa, F ;
Nakajima, J ;
Kamimura, H ;
Yasuda, I .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2001, 121 (10) :765-769
[9]   A validated high-performance liquid chromatographic method for the determination of glibenclamide in human plasma and its application to pharmacokinetic studies [J].
Niopas, I ;
Daftsios, AC .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (3-4) :653-657
[10]  
*SOC JAP PHARM, 2002, JAP PHARM COD